
Opinion|Videos|August 21, 2024
Managing Adverse Events in Novel Friedreich’s Ataxia Therapy
A key opinion leader outlines common adverse events associated with omaveloxolone treatment in Friedreich's ataxia patients and describes strategies used to manage or minimize these adverse effects.
Advertisement
Episodes in this series

- What adverse events are typically encountered with omaveloxolone, what strategies do you employ to mitigate or address them effectively and under what circumstances should omaveloxolone be discontinued, if at all?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
In CLL, New Therapies Offer Potential for Personalized Approaches
4
ICYMI: Highlights From CROI 2025
5











































